Discovery of a peroxisome proliferator activated receptor gamma (PPARgamma) modulator with balanced PPARalpha activity for the treatment of type 2 diabetes and dyslipidemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples